Skip to main content
2026 Prospectus
The Healthcare ExecutiveExecutive News

House bill targets rural reclassification. What urban systems could lose

A new House bill would shut down the dual urban-rural status hundreds of hospitals now use, and finance teams at reclassified systems should size the exposure before it gains momentum.

House bill targets rural reclassification. What urban systems could lose

Executive takeaway

If your system relies on rural reclassification, put a dollar figure on it now. The bill is early, but the policy question it raises will not go away.

Article

What the bill would do

Reps. Dave Taylor of Ohio and Carol Miller of West Virginia introduced H.R. 7409, the Defend Rural Health Act of 2026, on Feb. 5. It has been referred to the House Ways and Means Committee.

The bill attacks so-called dual classification, in which a hospital located in an urban area reclassifies as rural for some Medicare purposes while also receiving an urban wage index through the Medicare Geographic Classification Review Board. Under the text:

  • Narrower path to rural status. Urban hospitals applying on or after Oct. 1, 2026, could reclassify as rural only through a subset of the current criteria. The pathway based on qualifying as a rural referral center or sole community hospital would no longer be available, and state-law rural designations would count only if in effect by Jan. 1, 2026.
  • No more dual status. Starting with fiscal years beginning Oct. 1, 2026, the review board could not approve a geographic reclassification for a hospital that is being treated as rural.
  • A 2029 cliff. Beginning Oct. 1, 2029, hospitals already reclassified would lose rural treatment unless they show they meet the remaining criteria.

Why it matters financially

The sponsors say the number of dually classified hospitals grew from three in 2017 to about 425 by 2023, after federal court rulings in 2015 and 2016 found CMS lacked authority to block the practice. Rural status can open a lower disproportionate share threshold for 340B eligibility, room to grow graduate medical education funding, and potential special designations, while the review board reclassification can preserve a higher urban wage index.

For an academic or large urban system that has stacked these benefits, the combined effect touches inpatient rates, drug acquisition costs and residency funding at once. The sponsors frame the practice as diverting resources from smaller rural facilities, and they named hospitals in Manhattan, Boston and San Francisco as beneficiaries.

How seriously to take it

This is a newly introduced bill that has only been referred to committee, so passage is far from assured. But it lands while rural funding is politically prominent and lawmakers are looking for ways to direct Medicare dollars to smaller facilities. Even if the bill stalls, the argument it makes could shape future payment debates.

Next steps for leaders

  • Inventory every facility using rural reclassification or review board status, and the benefit each one carries.
  • Quantify the 340B, wage index and residency cap impact if dual status ended in fiscal 2027.
  • Brief government relations and the board audit or finance committee on the scenario.

Archive entry for Feb 12, 2026, added Nov. 11, 2026.

Sources

Quarterly Brief

Get the Quarterly Brief by email.

A practical executive agenda for hospital and health system leaders, four times a year.

Sent by The Healthcare Executive. Unsubscribe at any time. See our Privacy Policy.